Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Glass House Brands Announces Appointment of Jon DeCourcey as Vice President of Investor Relations
Posted On Wednesday, March 05, 2025
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
Posted On Wednesday, March 05, 2025
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
Posted On Wednesday, March 05, 2025
ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms
Posted On Wednesday, March 05, 2025
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
Posted On Wednesday, March 05, 2025
Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates
Posted On Wednesday, March 05, 2025
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
Posted On Wednesday, March 05, 2025
Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual
Posted On Wednesday, March 05, 2025
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Posted On Wednesday, March 05, 2025
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Posted On Wednesday, March 05, 2025
Plus Therapeutics Announces New Employment Inducement Grants
Posted On Wednesday, March 05, 2025
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
Posted On Wednesday, March 05, 2025
Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
Posted On Wednesday, March 05, 2025
Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination
Posted On Wednesday, March 05, 2025
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
Posted On Wednesday, March 05, 2025
Longeveron® to Present at the 37th Annual Roth Conference
Posted On Wednesday, March 05, 2025
ALX Oncology Highlights Focused Evorpacept Development Plan, Clinical Progress and Corporate Updates at R&D Day Webcast Event
Posted On Wednesday, March 05, 2025
Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference
Posted On Wednesday, March 05, 2025
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference
Posted On Wednesday, March 05, 2025
Grove AI Awarded the SCOPE Participant Engagement Award for Its AI-Powered Digital Staff and Platform for Clinical Trial Operations
Posted On Wednesday, March 05, 2025
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
Posted On Wednesday, March 05, 2025
Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results
Posted On Wednesday, March 05, 2025
Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit
Posted On Wednesday, March 05, 2025
iTeos Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Posted On Wednesday, March 05, 2025
KSQ Therapeutics Appoints Kristen Hege, M.D., to its Board of Directors
Posted On Wednesday, March 05, 2025

Print